Bradley Foster & Sargent’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$974K Hold
37,862
0.01% 312
2026
Q1
$779K Buy
37,862
+174
+0.5% +$3.92K 0.01% 325
2025
Q4
$894K Buy
37,688
+1,192
+3% +$29K 0.01% 310
2025
Q3
$909K Hold
36,496
0.01% 305
2025
Q2
$839K Hold
36,496
0.01% 315
2025
Q1
$819K Hold
36,496
0.01% 291
2024
Q4
$713K Sell
36,496
-11,430
-24% -$227K 0.01% 314
2024
Q3
$873K Sell
47,926
-14,972
-24% -$286K 0.01% 298
2024
Q2
$1.09M Buy
62,898
+16,613
+36% +$294K 0.02% 263
2024
Q1
$907K Buy
46,285
+32,364
+232% +$684K 0.02% 280
2023
Q4
$321K Buy
+13,921
New +$312K 0.01% 389

Other funds holding PRVA

Bradley Foster & Sargent's PRVA Position: Q2 2026 in Review

Bradley Foster & Sargent held its Privia Health (PRVA) position steady in Q2 2026 at 37,862 shares worth $974K. The position accounts for 0.01% of the portfolio, ranked #312.

Bradley Foster & Sargent first reported a position in PRVA in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.09M in Q2 2024. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Bradley Foster & Sargent held 37,862 shares of Privia Health worth $974K as of Q2 2026.
  • Bradley Foster & Sargent left its Privia Health share count unchanged in Q2 2026.
  • Privia Health made up 0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #312 holding.
  • Bradley Foster & Sargent first reported a position in Privia Health in Q4 2023 and has held it in 11 quarters since.
  • Bradley Foster & Sargent's Privia Health position peaked at $1.09M in Q2 2024.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.